Inaktiver Wert

Kythera Biopharmaceuticals Inc Aktie

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

Kythera Biopharmaceuticals : Allergan Successfully Completes Kythera Acquisition; Adds Game-Changing KYBELLA Treatment for Double-Chin	08.10.15
Kythera Biopharmaceuticals : ® Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	08.10.15
Allergan : forecasts second-half revenue above $8 billion	28.09.15
KYTHERA(R) Biopharmaceuticals Submits Investigational New Drug Application for KYTH-105 to Treat Androgenetic Alopecia, or Male Pattern Hair Loss	22.09.15
KYTHERA(R) Biopharmaceuticals Submits Marketing Authorization Application in the European Union for ATX-101 as First-in-Class Treatment for the Reduction of Submental Fat	18.08.15

Manager	Titel	Alter	Seit
Ambrose Bailey PSD	President	60	01.10.15
Maria Hilado BRD	Director/Board Member	59	01.10.15
Jere D. Fellmann PRN	Corporate Officer/Principal	72	01.06.12

Aufsichtsräte	Titel	Alter	Seit
Maria Hilado BRD	Director/Board Member	59	01.10.15
Ambrose Bailey PSD	President	60	01.10.15
Steven Fagien BRD	Director/Board Member	-	-

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31 %	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+0,56 %	95,28 Mrd.
ARGENX SE	+1,69 %	22,15 Mrd.
BIONTECH SE	-17,37 %	21,02 Mrd.
GENMAB A/S	-9,30 %	18,15 Mrd.
WUXI APPTEC CO., LTD.	-41,01 %	16,74 Mrd.
BEIGENE, LTD.	-14,85 %	16,05 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+3,21 %	13,68 Mrd.
SAREPTA THERAPEUTICS, INC.	+33,54 %	12,17 Mrd.